Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jared Benjamin
Observed name:
Benjamin, Jared
Institutions:
University of Toronto,
Rutgers New Jersey Medical School,
Icahn School of Medicine at Mount Sinai
Observed institutions:
University of Toronto,
University of Rochester Medicine,
Rutgers New Jersey Medical School,
Icahn School of Medicine at Mount Sinai
ORCID:
0000-0002-0328-0461
Observed ORCID:
0000-0002-0328-0461
OpenAlex ID:
A5082329297
Adaptive multi-epitope targeting and avidity-enhanced nanobody platform for ultrapotent, durable antiviral therapy
2024
·
Yufei Xiang
, Jialu Xu
, et al.
·
Cell
·
50
Nirmatrelvir and molnupiravir maintain potent in vitro and in vivo antiviral activity against circulating SARS-CoV-2 omicron subvariants
2024
·
Romel Rosales
, Briana L. McGovern
, et al.
·
Antiviral Research
·
13
Mutations accumulated in the Spike of SARS-CoV-2 Omicron allow for more efficient counteraction of the restriction factor BST2/Tetherin
2024
·
Yuhang Shi
, Sydney Simpson
, et al.
·
PLoS Pathogens
·
12
Discovery of potent SARS-CoV-2 nsp3 macrodomain inhibitors uncovers lack of translation to cellular antiviral response
2024
·
Alpha A. Lee
, Isabelle Amick
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
11
PDF
HIV Nef-mediated Ubiquitination of BCL2: Implications in Autophagy and Apoptosis
2021
·
Sergio Castro-Gonzalez
, Sydney Simpson
, et al.
·
Frontiers in Immunology
·
11
PDF
Residues T48 and A49 in HIV-1 NL4-3 Nef are responsible for the counteraction of autophagy initiation, which prevents the ubiquitin-dependent degradation of Gag through autophagosomes
2021
·
Sergio Castro-Gonzalez
, Yuexuan Chen
, et al.
·
Retrovirology
·
6
PDF
Discovery of Coronavirus Main Protease Inhibitors with Enhanced Brain Exposure and Potent Oral Efficacy in SARS-CoV-2 and MERS Infection Models
2026
·
Luca Lizzadro
, Jiapeng Li
, et al.
·
Journal of Medicinal Chemistry
·
2
Linking Biochemical and Cellular Efficacy of MERS Coronavirus Main Protease Inhibitors
2026
·
Van N. T. La
, Noa Lahav
, et al.
·
ACS Pharmacology & Translational Science
·
1
PDF
Generative design of de novo AAV vectors with unique serological profiles
2026
·
Michael Garton
, Giulio Chiesa
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
Pan-Coronavirus Protease Engagement and Differentiated Pharmacology of Antiviral Candidate CMX990
2026
·
N. G. R. Dayan Elshan
, Karen C. Wolff
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
CCDC 2478565: Experimental Crystal Structure Determination
2026
·
Lizzadro, Luca
, Li, Jiapeng
, et al.
·
The Cambridge Structural Database
CCDC 2478564: Experimental Crystal Structure Determination
2026
·
Lizzadro, Luca
, Li, Jiapeng
, et al.
·
The Cambridge Structural Database
Acquired Amegakaryocytic Thrombocytopenia Presenting as Pancytopenia in a Patient With Chronic Lymphocytic Leukemia: A Case Report
2026
·
Christopher C. Chen
, Anand Shah
, et al.
·
Case Reports in Hematology
PDF
Structure-Activity Relationship Studies Towards Analogues of Pleconaril as Novel Enterovirus-D68 Capsid-Targeting Antivirals
2025
·
David L Cousins
, Ed J Griffen
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
Show more works
View as search
Works count:
14
Citation count:
106
H-index:
6
I10-index:
5
Year
Topic
Type